IFNA1 and pulmonary arterial hypertension: Interferon beta (IFN-β) and interferon alpha (IFN-α) were listed among the substances with a possible risk of PAH induction in the guidelines of the European Society of Cardiology and the European Respiratory Society in 2015 (Galiè et al., 2015).